SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-001038
Filing Date
2021-08-09
Accepted
2021-08-09 09:01:18
Documents
59
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lbph-20210630.htm   iXBRL 10-Q 2704495
2 EX-31.1 lbph-20210630ex31_1.htm EX-31.1 17191
3 EX-31.2 lbph-20210630ex31_2.htm EX-31.2 17203
4 EX-32.1 lbph-20210630ex32_1.htm EX-32.1 18796
5 GRAPHIC img7670367_0.jpg GRAPHIC 368328
  Complete submission text file 0000950170-21-001038.txt   9919754

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lbph-20210630_pre.xml EX-101.PRE 285952
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lbph-20210630.xsd EX-101.SCH 41194
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lbph-20210630_cal.xml EX-101.CAL 30111
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lbph-20210630_lab.xml EX-101.LAB 357020
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lbph-20210630_def.xml EX-101.DEF 172018
11 EXTRACTED XBRL INSTANCE DOCUMENT lbph-20210630_htm.xml XML 1990765
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40192 | Film No.: 211154822
SIC: 2834 Pharmaceutical Preparations